Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
IL21 VHH recombinant monoclonal antibody
IL22 VHH recombinant monoclonal antibody
IL22RA1 VHH recombinant monoclonal antibody
IL23A VHH recombinant monoclonal antibody
IL27 VHH recombinant monoclonal antibody
IL2RA VHH recombinant monoclonal antibody
IL31 VHH recombinant monoclonal antibody
IL31RA VHH recombinant monoclonal antibody
IL33 VHH recombinant monoclonal antibody
IL3RA VHH recombinant monoclonal antibody
IL4 VHH recombinant monoclonal antibody
IL4R VHH recombinant monoclonal antibody